Tuesday, December 06, 2016 2:53:46 PM
What they will find is that their DRUG Sucanon is the ONLY Type 2 DRUG with ZERO SIDE-EFFECTS.
What they will find is that the most prestigious HOSPITAL IN MEXICO just conducted a large clinical trial of the company's DRUG against Metformin (most proscribed Type 2 drug).
What they will find is a company whose DRUG was APPROVED in CANADA (not exactly a country known for approving fakes).
What they will find is a company whose DRUG is about to be APPROVED IN INDIA, with Canagen Pharma as the distributor.
What they will find is a company that has limited financial resources so capital is always an issue.
What they will find are LOYAL SHAREHOLDER (even DOCTORS!!) who understand and accept the risks.
It's not an investment for everybody, but if like me, you believe that sooner or later a DRUG that address the BIGGEST GLOBAL HEALTH CONCERN OF OUR TIMES AND HAS ZERO SIDE EFFECTS is going to be valuable at some point in the future, then it deserves a look.
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM